Myeloablative Allo Stem Cell Transplant

Myeloablative Allogeneic Hematopoietic Stem Cell Transplant With Related or Unrelated Donor for Hematological Disorders

More Information

Trial Status
Accepting patients
Trial Phase
Phase 2
Enrollment
300 patients (estimated)
Sponsors
University of Minnesota - Masonic Cancer Center
Tags
Allogeneic Stem Cell Transplant, Chemotherapy, Radiation Therapy
Trial Type
Treatment
Last Update
2 months ago
SparkCures ID
1197
NCT Identifier
NCT03314974

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print this trial to share with your doctor.

We can help answer any questions and connect you (or your patient) with the study team.

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.